
December 2023, Vol 311, No 7980
Top news stories


Fewer than 5,000 people prescribed anticholesterol drug inclisiran in primary care as of July 2023

Pharmacy technicians may prepare and dispense medicines without supervision under government proposals

Life cycle adjustment left out of statutory scheme on pricing of NHS medicines
Features

Revisiting 2023: a look back at the year in pharmacy

How has 2023 stacked up for the pharmacy sector?

Inclisiran: the ‘extremely unusual’ political influence behind the novel drug’s approval

Routine delays: the cancer services struggling to treat patients on time
Opinion

PJ view: Transparency in the science behind government policy is vital

The vision for supervision

How we are igniting change through the chief pharmaceutical officer’s Fellowship scheme

Elevating research within pharmacy

Community pharmacies’ full potential is trapped in an iron cage of bureaucracy

Pharmacy has a role in innovation adoption in healthcare systems
Learning & CPD

Learning and CPD: 2023 in review

Top ten articles of 2023 from the Royal Pharmaceutical Society’s research journals

Case-based learning: testosterone deficiency

Introduction to clinical assessment for prescribers

Test yourself: the 2023 CPD and Learning quiz

Pharmaceutical considerations for fracture management in adults

Prostate cancer: recognition and diagnosis
Women to Watch

Exceptional pharmacy professionals hailed in The Pharmaceutical Journal’s 2023 ‘Women to Watch’ list

Abeer Aamir

Ifesinachi Anyamene

Chloe Barclay

Elaine Ferguson

Maryam Jetha
